Sorrento Therapeutics is filing for bankruptcy following a yearslong legal dispute. The biotech submitted its Chapter 11 paperwork Monday, per an SEC filing, after losing an arbitration battle to billionaire Patrick Soon-Shiong’s NantCell in December. The pai…